TL;DR
This paper introduces a deep learning model that predicts drug-target binding affinities using only sequence data, outperforming existing methods on benchmark datasets.
Contribution
It presents a novel CNN-based approach that models protein sequences and drug representations for affinity prediction, using only sequence information.
Findings
The CNN model achieved the best Concordance Index on large benchmark datasets.
It outperformed state-of-the-art methods like KronRLS and SimBoost.
Sequence-based deep learning is effective for binding affinity prediction.
Abstract
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary classification, where the goal is to determine whether a DT pair interacts or not. However, protein-ligand interactions assume a continuum of binding strength values, also called binding affinity and predicting this value still remains a challenge. The increase in the affinity data available in DT knowledge-bases allows the use of advanced learning techniques such as deep learning architectures in the prediction of binding affinities. In this study, we propose a deep-learning based model that uses only sequence information of both targets and drugs to predict DT interaction binding affinities. The few studies that focus on DT binding affinity prediction use either 3D…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
